_________________
January 2, 2024 | Founded in Spain over eight decades ago, the company focuses on developing over the counter (OTC) drugs and products. Since then, it has grown its production to include prescription (RX) drugs and launched its first generic product on the Spanish market.
ValGenesis and Medhini are working to enable customers with robust manufacturing intelligence solutions from ValGenesis – VLMS, iRisk, Process Manager, Process Insight, and e-Logbook.
AmplifyBio is growing rapidly in the pursuit of creating the leading technology-integrated service organization for the commercialization of advanced therapies.
Acumen Analytics, a leader in intelligent digital transformation, have partnered to provide advanced risk management solutions for life sciences companies.
ValGenesis digital validation platform was chosen to enhance their global validation processes, underscoring its commitment to elevating CAR-T therapy production standards.
ValGenesis will provide technology transfer services and streamline multiple processes at the company’s manufacturing site in Brazil that produces a high-volume commercial product.
ValGenesis VLMS product suite alongside Soluciones GXP’s immense regulatory expertise across the life sciences sector in Latin America (LATAM).
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a UK-based global full-service contract research organization (CRO), selected ValGenesis VLMS to digitize its corporate validation process.
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a US government contractor selected ValGenesis VLMS to digitize its corporate validation process.
Canadian biotechnology company selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize its corporate validation process.